tiprankstipranks
Recro Pharma (REPH)
NASDAQ:REPH
US Market

Recro Pharma (REPH) Stock Investors

0 Followers
Based on 576,112 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold REPH
On average, investors allocate 0.69% of their portfolios to REPH
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding REPH

4.6%
Last 7
Days
0.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding REPH, out of 576,112 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

REPH Investor Activity

No data currently available
Based on the activity of 46,516 investors who made their portfolios public
The table shows changes in REPH in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

REPH Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Homology Medicines
3.23%
-1.17%
+0.33%
198.88M
Healthcare
Inovio Pharmaceuticals
3.68%
-0.77%
+1.20%
789.17M
Healthcare
Cytokinetics
4.86%
+0.55%
+8.40%
3.02B
Healthcare
Zynga
5.75%
-1.25%
-4.08%
10.33B
Technology
Durect
2.15%
+0.55%
-4.54%
148.18M
Healthcare
Veru
2.81%
+1.99%
-0.09%
406.66M
Healthcare
Aquestive Therapeutics
5.05%
-1.96%
-4.31%
118.60M
Healthcare
ObsEva SA
5.54%
-0.12%
-0.56%
99.38M
Healthcare
G1 Therapeutics
6.97%
+0.22%
+3.76%
388.62M
Healthcare
Sorrento Therapeutics
4.14%
+0.55%
+2.69%
873.27M
Healthcare
Based on the activity of 576,112 active portfolios
Open your Smart Portfolio

REPH Investor Analysis

REPH investors under 35

Under 35

29.0%
Last 30 days
Holdings Change
13.3%
of REPH holders
are under 35
Average Segment Performance
Average P/E Ratio-
Beta1.16
Dividend Yield1.39%
REPH investors between 35–55

Between 35–55

15.4%
Last 30 days
Holdings Change
80.0%
of REPH holders
are between 35–55
Average Segment Performance
Average P/E Ratio-
Beta1.25
Dividend Yield1.54%
REPH investors over 55

Over 55

100.0%
Last 30 days
Holdings Change
6.7%
of REPH holders
are over 55
Average Segment Performance
Average P/E Ratio-
Beta1.15
Dividend Yield1.91%
Overview of age group and performance of REPH stock investors
See who invests in REPH according to age group and performance.

FAQ

How many retail Investors hold REPH?
<0.1% of TipRanks' retail investors hold REPH in their portfolios.
    What is REPH Investor Sentiment?
    REPH’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of REPH in the last 7 days?
      ▼ 4.6% of TipRanks' retail investors changed their holding of REPH in the last 7 days.
        What percentage of retail investors changed their holding of REPH in the last 30 days?
        ▲ 0.1% of TipRanks' retail investors changed their holding of REPH in the last 30 days.
          What is the average age of retail investors who hold REPH?
          The average age of REPH Holders is between 35–55.
            What other stocks have REPH investors also bought?
            REPH Investors also bought FIXX, INO, CYTK, ZNGA, DRRX, VERU, AQST, OBSV, GTHX, SRNE.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              RAINRain Therapeutics
              TMCITreace Medical Concepts
              IMPLImpel NeuroPharma Inc
              BPTSBiophytis
              TRYPTryp Therapeutics Inc
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis